Astigmatism clinical trials
16 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Clinical Performance of Verofilcon A Toric Contact Lenses
- Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
- Contoura With Phorcides Compared to Wavefront Optimized LASIK
- A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
- Clareon TruPlus Study
- Clinical Evaluation of WaveLight Plus LASIK
- Patient Reported Outcomes With WaveLight Plus LASIK
- Comfort and Vision With TOTAL30 Multifocal Lenses
- North American Comfilcon A Clinical Study
- An Evaluation of LASIK, SMILE and PRK Surgery in Physicians
- OCT in Diagnosis of Irregular Corneas
- Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day
- Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery
- Optimization for Toric Contact Lenses
- SMILE Surgery in One Eye Compared to Ray Tracing-guided LASIK Surgery in the Fellow Eye
- Revive Toric RWE Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Astigmatism” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.